Intrinsiqq
Elliptic Laboratories ASA logo

Elliptic Laboratories ASA

ELABS.XOSL

Compare

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market CapNOK 283M
EPS-NOK 1.17
P/E-0.19
P/FCF-5.90
EV/EBITDA38.95
FCF Yield–
Div. Yield–
Net Debt/FCF0.5x
Elliptic Laboratories ASA intrinsic value
52-Week Range
€0.18€0.64

Profitability & Returns

Revenue (TTM)

NOK 114M

▼ -23.2% YoY

Net Income (TTM)

-NOK 125M

▼ -1661.9% YoY

Op. Margin

-26.35%

▼ -46.4pp YoY

ROIC

-13.68%

▼ -13.6pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-NOK 48M

▲ +43.8% YoY

Op. Cash Flow (TTM)

-NOK 23M

▲ +121.6% YoY

Net Debt

-NOK 25M

Net Cash Position

Cash & Equiv.

NOK 38M

3Y CAGR: +24.8%

Continue Research

Peers

Software - Infrastructure · Pick stocks to compare with ELABS.XOSL

CompareIntrinsic value
PEXIP.XOSLPexip Holding ASA
kr 66.20-4.34%47
SMOP.XOSLSmartoptics Group ASA
€4.76-5.56%49
ENERG.XOSLEnergeia AS
€0.65-1.21%10
HDLY.XOSLHuddly AS
€1.46-16.57%10
PLT.XOSLpoLight ASA
€1.18-4.82%25
HUDL.XOSLHuddlestock Fintech AS
€0.05+1.22%0
AIX.XOSLAyfie Group AS
€0.29-0.35%10
OTOVO.XOSLOtovo ASA
€0.78-2.02%20

Elliptic Laboratories ASA (ELABS.XOSL) in four numbers

Fair value (revenue)
€0.39
Price €0.22 is 44% below it.
Intrinsic Value
Quality score
40/100
Best check: revenue growth, 21.7%. Weakest: return on capital, -13.7%.
Quality
Dividend
None
No dividend in the company filings we hold.
Dividends
P/E
-0.19
Negative: a loss over the last twelve months. Price to free cash flow -5.90.
Financials

Questions about Elliptic Laboratories ASA

Is Elliptic Laboratories ASA (ELABS.XOSL) overvalued?

At €0.22, Elliptic Laboratories ASA's price is 44% below the €0.39 a share fair value that Intrinsiqq's calculator gets from its revenue. The growth behind that figure is yours to set on the Intrinsic Value tab. See how to tell if a stock is overvalued.

What is Elliptic Laboratories ASA's fair value?

Intrinsiqq's calculator puts Elliptic Laboratories ASA's fair value at €0.39 a share. It grows revenue per share 24.3% a year for 5 years, applies an exit P/S of 2.4, and works back at a 10% yearly return. A 25% margin of safety gives a buy-below price of €0.29. Every input can be changed on the Intrinsic Value tab.

Is Elliptic Laboratories ASA a high-quality business?

Elliptic Laboratories ASA scores 40 out of 100 on Intrinsiqq's quality score, which makes it a mixed business on these measures. The score blends 6 checks computed from company filings. Its best check is revenue growth at 21.7%, and its weakest is return on capital at -13.7%. The Quality tab shows every check against its target.

Does Elliptic Laboratories ASA (ELABS.XOSL) pay a dividend?

No. Elliptic Laboratories ASA (ELABS.XOSL) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold. Nor has its share count fallen meaningfully over the last twelve months, so cash is kept in the business. The Dividends tab shows its cash returns.

Source: company filings. Price: last close 6 Nov 2026. How this is calculated. Sector medians are approximate S&P 500 benchmarks and update periodically. Analysis, not investment advice.

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ELABS.XOSL

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.